According to a new market report published by Lucintel, the future of the platelet rich plasma (PRP) market looks promising with opportunities in orthopedics, cosmetic surgery and dermatology, ophthalmic surgery, neurosurgery, and general surgery applications. The global platelet rich plasma market is expected to grow with a CAGR of 13% from 2020 to 2025. The major drivers for this market are increasing demand for plasma therapy in therapeutic areas, rising geriatric population, and growing sports surgeries.
To download report brochure, please go to https://www.lucintel.com/platelet-rich-plasma-market.aspx and click "download brochure" tab from the menu
Platelet rich plasma is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells and helps in blood clotting as well as enhances the healing of tendons, muscles, and ligaments. In this market, pure PRP, leukocyte-rich PRP, and leukocyte-rich fibrin PRP are the major products. Lucintel forecasts that pure PRP will remain the largest product segment over the forecast period, as it provides effective results in bone regeneration and is less inflammatory as compared to other products.
Within this market, orthopedics will remain the largest segment by application over the forecast period due to increasing aging population and rising incidence of road accidents.
North America will remain the largest region over the forecast period due to increasing application areas of platelet rich plasma in therapeutics, rising cases of orthopedic disorders, and presence of major players of PRP in the region.
Arthrex, Terumo BCT, EmCyte, DePuy Synthes, Zimmer Biomet, Stryker, Glofinn, DR. PRP America, Harvest Technologies, and Adistem are among the major suppliers in the global platelet rich plasma market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global platelet rich plasma market by product, origin, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Platelet Rich Plasma Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global platelet rich plasma market by product, origin, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Pure PRP
Leukocyte-Rich PRP
Leukocyte-Rich Fibrin PRP
By Origin [Value ($ Million) shipment analysis for 2014 – 2025]:
Autologous PRP
Allogeneic PRP
Homologous PRP
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Orthopedics
Cosmetic Surgery and Dermatology
Ophthalmic Surgery
Neurosurgery
General Surgery
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Orthopedic Clinics
Dermatology Clinics
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.